Haemonetics Corp (NYSE:HAE)
$ 83.51 -1.75 (-2.05%) Market Cap: 4.19 Bil Enterprise Value: 5.21 Bil PE Ratio: 34.65 PB Ratio: 4.79 GF Score: 76/100

Haemonetics Corp Investor Day Transcript

Jun 29, 2022 / 02:00PM GMT
Release Date Price: $65.97 (+3.09%)
Olga Guyette
Haemonetics Corporation - Director of IR

Well, good morning, everyone, and thank you for joining us today in person and virtually. I'm Olga Guyette, Senior Director of Investor Relations and Treasury, and it's my pleasure to welcome you to Haemonetics 2022 Investor Day.

Before we begin the presentation, I would like to remind you that statements made today may contain forward-looking information, so typical safe harbor and risk factors apply. The slide you see now provides details about risks to those forward-looking statements and where to obtain additional information about risk factors and are in our latest SEC filings. Consistent with our past practices, we may refer to non-GAAP financial measures.

Please note that these measures exclude certain charges and income items. Please refer to Appendix A in this presentation for a full list of excluded items and reconciliations to our GAAP results. Additionally, in order to protect customer confidentiality, -- we will not be able to discuss any customer-specific detail except as disclosed previously. We have a full agenda for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot